Your browser doesn't support javascript.
loading
Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against Neisseria meningitidis and Streptococcus pneumoniae.
Lewis, Lisa A; Panicker, Sandip; DeOliveira, Rosane B; Parry, Graham C; Ram, Sanjay.
Afiliación
  • Lewis LA; Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605; and lisa.lewis@umassmed.edu.
  • Panicker S; Bioverativ, a Sanofi company, Waltham, MA.
  • DeOliveira RB; Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605; and.
  • Parry GC; Bioverativ, a Sanofi company, Waltham, MA.
  • Ram S; Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605; and.
Immunohorizons ; 3(11): 519-530, 2019 11 05.
Article en En | MEDLINE | ID: mdl-31690560

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Streptococcus pneumoniae / Complemento C1 / Cápsulas Bacterianas / Anticuerpos Antibacterianos / Neisseria meningitidis Límite: Humans Idioma: En Revista: Immunohorizons Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Streptococcus pneumoniae / Complemento C1 / Cápsulas Bacterianas / Anticuerpos Antibacterianos / Neisseria meningitidis Límite: Humans Idioma: En Revista: Immunohorizons Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos